Hello new staff #5

Busra was previously working as an officer/coordinator for the Swedish aptitude test (Högskoleprovet) at Stockholm University. At Labmed she is working as an education officer for the department and coordinating the board of eduation.

During the last years Kristina has worked for the Red Cross, fifteen years as a lecturer at the Red Cross University College and three years at the Swedish Red Cross International Dep. as a health advisor. At Labmed and Division of Pharmacology she will plan and conduct education within the laboratory disciplines

Staffan has a PhD in physical chemistry and has previously been teaching at Hagströmska gymnasiet in Uppsala. At Labmed Staffan will teach mainly in chemistry.

Flora has completed a double master’s degree in Genetics and Bioinformatics at Paris Diderot University in France. She was previously at KI as a master student, but has come back to pursue her PhD in Ujjwal Neogi's group. Her Ph.D. project is about developing multi-omics pipelines in HIV-associated immune-aging.  She is working mostly on transcriptomics, proteomics, and metabolomics data obtained from cells and plasma from HIV-infected patients following antiretroviral therapy. Her research aims to find biomarkers and pathways related to immune-aging in HIV context using single-cell, multi-omics, system biology, and machine learning approaches.

Shuba obtained her PhD from Department of Laboratory Medicine in 2016 in Prof. Anna Karlsson’s group. During her PhD she studied the role of mitochondrial DNA in human inherited diseases and used the knowledge to derive therapeutic targets. She did a postdoctorate in Asst. Prof. Christine Cheung’s group, Laboratory of Molecular and Vascular Medicine, NTU, Singapore. Her project focused on functional elucidation of biomarkers for cerebrovascular disorders such as stroke and patient-specific approach for improved prognosis and diagnosis. She joined as a postdoc in Ujjwal Neogi’s group, Division of Microbiology in Sept 2019. Her research is aimed at unravelling intracellular metabolic pathways for accelerated ageing in people living with HIV-1 on ART treatment using high-throughput omics platforms and experimental models.

Rafael comes from the Hospital General Gregorio Marañon, Madrid, Spain where he was working in the use of nanotechnology against sexual transmited diseases. In Anders Sönnerborg research group Rafael will be working in antiviral research, HIV-1.